TG and COVID-19: However, according to a systematic review of seven studies and 1237 patients with COVID-19, the prevalence of thyroid dysfunction, defined as abnormalities in levels of the thyroid stimulating hormone (TSH) and/or thyroid hormones, is highly variable in COVID-19 disease, ranging from 13 to 64% [13].